Imugene Limited
IUGNF
$0.1741
-$0.0073-4.02%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -45.08% | -118.33% | -284.54% | -191.19% | -108.04% |
| Total Depreciation and Amortization | 133.97% | 105.38% | 75.98% | 26.76% | -14.02% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.08% | 132.36% | 984.62% | 1,305.18% | 2,642.97% |
| Change in Net Operating Assets | 690.73% | 690.73% | 690.73% | 190.96% | 109.21% |
| Cash from Operations | -52.67% | -108.69% | -207.68% | -107.26% | -33.89% |
| Capital Expenditure | -32.54% | -125.27% | -- | -5,298.21% | -2,699.45% |
| Sale of Property, Plant, and Equipment | 14,478.46% | 14,478.46% | 14,478.46% | 14,339.39% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 34.70% | -57.42% | -330.87% | -623.65% | -1,822.57% |
| Cash from Investing | 9.95% | -75.15% | -649.39% | -1,386.52% | -9,836.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -676.10% | -779.24% | -944.37% | -490.23% | -53.85% |
| Issuance of Common Stock | -99.06% | -61.73% | -39.26% | -40.32% | -41.36% |
| Repurchase of Common Stock | -- | -- | -- | 0.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 64.76% | 45.75% | 46.08% | 46.42% |
| Cash from Financing | -102.69% | -64.12% | -42.00% | -42.61% | -43.23% |
| Foreign Exchange rate Adjustments | -193.94% | -222.01% | -962.30% | 244.20% | 299.75% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -367.61% | -649.95% | -210.58% | -184.81% | -152.71% |